Skip to main content

General Dermatology News

A majority of patients with a symptomatic keloid treated with a 1064-nm Nd:YAG laser exclusively saw a total resolution in pain after treatment. The study results were published in Lasers in Surgery and Medicine.
Findings from a recent study found risankizumab improved both moderate to severe psoriasis symptoms and patients’ quality of life.
Findings from a recent randomized controlled trial showed a broad peroxisome proliferator-activated receptor agonist improved moderate to severe pruritus among patients with primary sclerosing cholangitis and primary biliary cholangitis.
A recent study found an artificial intelligence smartphone app may be a useful clinical tool for helping diagnosis skin diseases in patients with skin of color.
A recent study found rituximab infusions were associated with changes in heart rate and other cardiac adverse effects among patients with pemphigus.
A recent study used surveys to determine which therapies patients found effective for managing hidradenitis suppurativa pain.
A recent meta-analysis showed patients with hidradenitis suppurativa were more likely to have substance abuse disorders and several psychiatric comorbidities, highlighting the need for dermatologists to screen and refer patients for these conditions.
Findings from a recent study highlight several possible risk factors for frontal fibrosing alopecia.
Botulinum neurotoxin type A treatment was associated with improvements in hyperhidrosis signs and quality of life, according to a recent study.
Findings from a recent systematic review and meta-analysis showed an association between the development of bullous pemphigoid and the use of several medications.
Back to Top